Robotic Surgical Procedures
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
City TherapeuticsMA - Cambridge
1 programComparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right N/A
Huadong MedicineChina - Hangzhou
1 programComparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
Huadong MedicineComparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right
Clinical Trials (1)
Total enrollment: 4,000 patients across 1 trials
NCT07029464Huadong MedicineComparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right
Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis
Start: Jun 2025Est. completion: May 20274,000 patients
N/ANot Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.